title: Neuroleptics and enrichment environment treatment in memory disorders and other central nervous system function observed in prenatally stressed rats.
abstract: It is believed that the most effective method of treatment in schizophrenia is pharmacotherapy, in particular, the use of atypical neuroleptics like aripiprazole (ARI) and olanzapine (OLA). Moreover, studies of many authors have shown that enriched living conditions and tobacco smoke exposure can also affect the cognitive functions that are disturbed in the course of schizophrenia. The aim of the study was to find whether tobacco smoke and enrichment living conditions have the influence on cognitive functions in the newborn offspring of prenatally stressed rats and whether drugs such as ARI (1.5 mg/kg intraperitoneally (i.p.)) and OLA (0.5 mg/kg ip) in single and chronic treatment modify those functions (Morris water maze). The study (in the same conditions) also analyses immobility time (Porsolt test) and motor activity of animals that received ARI and OLA. It has been shown that ARI and OLA as well as enriched environment reduce cognitive function disorders and modify cognitive functions in rats exposed to tobacco smoke. In turn, current research has shown that nicotine has increased cognitive function disorders compared to the previous study (animals without tobacco smoke exposure).
authors: Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland.
authors: P
authors: P
authors: Ratajczak
authors: Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland elapharm@ump.edu.pl.
authors: E
authors: E
authors: Nowakowska
authors: Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland.
authors: K
authors: K
authors: Kus
authors: Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland.
authors: R
authors: R
authors: Danielewicz
authors: Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland.
authors: S
authors: S
authors: Herman
authors: Department of Toxicology, Poznan University of Medical Sciences, Poznan, Poland.
authors: A
authors: A
authors: Woźniak
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000068180:Aripiprazole / Q000008:administration & dosage / Q000627:therapeutic use; D001522:Behavior, Animal / Q000187:drug effects*; D001569:Benzodiazepines / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005865:Gestational Age; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D008569:Memory Disorders / Q000188:drug therapy* / Q000523:psychology; D009043:Motor Activity / Q000187:drug effects; D000077152:Olanzapine; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000188:drug therapy* / Q000523:psychology; D017208:Rats, Wistar; D012907:Smoking / Q000009:adverse effects*; D012931:Social Environment
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000068180:Aripiprazole; D000077152:Olanzapine
keywords: Schizophrenia; aripiprazole; enrichment environment; oplanzapine; prenatal stress